Related Experiment Videos
Porokeratosis and immunosuppression
P L Bencini1, A Tarantino, R Grimalt
1Istituto di Clinica Dermatologica I e Dermatologia Pediatrica Università di Milano, Ospedale Maggiore IRCCS, Italy.
The British Journal of Dermatology
|January 1, 1995
Summary
Immunosuppression may promote disseminated superficial porokeratosis (DSP) development. Sun exposure is not always essential for DSP in immunosuppressed patients, challenging previous hypotheses.
Area of Science:
- Dermatology
- Immunology
Background:
- Disseminated superficial porokeratosis (DSP) is a rare skin condition.
- Immunosuppression is a potential risk factor for various dermatological conditions.
Purpose of the Study:
- To investigate the clinical features and outcomes of DSP in immunosuppressed patients.
- To compare DSP characteristics between immunosuppressed and immunocompetent individuals.
Main Methods:
- Retrospective analysis of 24 immunosuppressed patients (Group A) with DSP.
- Comparison with 13 immunocompetent patients (Group B) with DSP.
- Evaluation of clinical features, family history, sun exposure, and disease progression.
Main Results:
- No significant differences in age, sex, or skin involvement area between groups.
- Lower incidence of family history in immunosuppressed patients (P=0.03).
- Similar sun exposure and significant worsening after sun exposure in both groups, suggesting sun is not always essential for DSP in immunosuppressed individuals.
Conclusions:
- Immunosuppression may be a significant factor in DSP development.
- Sun exposure's role in DSP development may be less critical in immunosuppressed patients.
- No skin cancers were observed in porokerotic lesions during follow-up.